|
|
|
|
Specialist builds a case for Crestor - A large number of patients at high risk of
Albany Care Chemist is well known for service and caring for the customers.We are even quoted on an Australian motivational selling programme for thinking outside the square. The special rapport with customers stems from the...
|
|
|
Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
AstraZeneca Patent Shown to be Invalid Based on New Prior Art; JSA Technologies Patent Study Yields Strong Invalidity Evidence NEW YORK, July 1 /PRNewswire/ -- Article One Partners, LLC has discovered new prior art impacting the validity of...
|
|
|
AZ wins on Iressa, could lose on Crestor
It's a mixed bag of AstraZeneca news today: The drugmaker finally won the Euro-OK for its oral cancer med Iressa.Thumbs up, yes? But the Crestor developments weren't so happy? One, a self-appointed patent watchdog group said it...
|
|
|
Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
AstraZeneca Patent Shown to be Invalid Based on New Prior Art; JSA Technologies Patent Study Yields Strong Invalidity Evidence NEW YORK, July 1 /PRNewswire/ -- Article One Partners, LLC has discovered new prior art impacting the validity of...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
- Free Subscription - Read Digital Magazine Now - View Publications STORY TOOLS A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor...
|
|
|
U.S. Group Questions AstraZeneca's Crestor Patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to defend...
|
|
|
US Group Questions AstraZeneca's Crestor Patent
A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to defend the Crestor patent...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to defend...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's (LSE:AZN.L - News; NYSE:AZN - News) patent for its cholesterol fighter Crestor invalid. AstraZeneca...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to defend...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON, July 1 (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's <AZN.L><AZN.N> patent for its cholesterol fighter Crestor invalid. AstraZeneca is...
|
|
|
AstraZeneca's Crestor patent questioned
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca's (AZN.L)(AZN.N) patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's <AZN.L><AZN.N> patent for its cholesterol fighter Crestor invalid. AstraZeneca is...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON, July 1 (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's (AZN.L)(AZN.N) patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON, July 1 (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's (AZN.L: Quote, Profile, Research)(AZN.N: Quote, Profile, Research) patent for its cholesterol...
|
|
|
AstraZeneca's Crestor patent questioned
- Free Subscription - Read Digital Magazine Now - View Publications STORY TOOLS A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca's patent for its cholesterol fighter Crestor...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to defend...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to defend...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON, July 1 (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. AstraZeneca is involved in litigation to...
|
|
|
Cholesterol OK? Statins Still Help Heart
-- Millions of people without established heart disease could benefit from cholesterol-lowering statin therapy even if they don't have high cholesterol, a new analysis suggests.Combined data from 10 trials that included more than 70,000...
|
|
|
U.S. group questions AstraZeneca's Crestor patent
WASHINGTON (Reuters) - A U.S.patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid. The patent group, Article One Partners LLC, did...
|
|
|
Lipitor Led to Wish for Short LIfe
In less than two years on Lipitor, I went from being able to climb the ancient temples at Angkor Wat, Cambodia, to being almost unable to walk to my mailbox.I felt like I had flu all the time. I had aches and pains in my fingers, arms,...
|
|
|
JUPITER Subanalysis Fuels Debate Over Role of Stat
Orlando, Fla.-The use of statins-what they do, what they don't do and who should receive them-remains a hot topic in cardiology and primary care.Presentations and debates at the American College of Cardiology (ACC) 2009 annual meeting...
|
|
|
When to treat blood pressure? Always!
patients?Actually called a meta-analysis, a study recently published in the British Medical Journal (May 19, 2009) and reported on in Journal Watch General Medicine (June 25, 2009), summed up 147 randomized hypertension (high blood...
|
